Small bowel motility: comparison of the effects of an anticholinergic agent, this agent plus a tranquilizer, and a placebo
Rider, J.A.
Current Therapeutic Research 20(2): 142-148
1976
ISSN/ISBN: 0011-393X PMID: 821714 Document Number: 108626
Document emailed within 1 workday
Related Documents
Short, C.E.; Miller, R.L. 1978: Comparative evaluation of the anticholinergic agent glycopyrrolate as a preanesthetic agent Veterinary Medicine-Small Animal Clinician 73(10): 1269-1273Zhang, Y.-F.; Yu, Y.-F.; Lu, S. 2009: Comparison of single-agent docetaxel versus docetaxel plus platinum combination agent in second-line treatment for advanced non-small cell lung cancer Zhonghua Yi Xue Za Zhi 89(22): 1544-1548
Frenken, C.W.; Nuijten, S.T. 1984: Flunarizine--a new agent for migraine prevention. Results of a double-blind comparison with placebo Fortschritte der Medizin 102(12): 349-351
Murmann, W.; Carminati, G.M.; Cattaneo, R. 1974: Pharmacology of zolimidine (2-(p-methylsulfonylphenyl)-imidazo (1,2-a) pyridine) a new non-anticholinergic gastroprotective agent. III). Gastric antisecretory activity, antagonism against acid hypersecretion induced by pentagastrin and histamine, and other effects Panminerva Medica 16(10): 335-346
Sun, D.C. 1978: Use of anticholinergic agent in duodenal ulcer Arizona Medicine 35(11): 724
Romański, K.W. 2010: Dose-related effects of cerulein short infusions on proximal small bowel motility in sheep Journal of the South African Veterinary Association 81(1): 27-32
De Schepper, A.; Wollaert, F.; Reyntjens, A. 1978: Effects of oral domperidone on gastric emptying and motility. a double-blind comparison with placebo and metoclopramide Arzneimittel-Forschung 28(7): 1196-1199
Saletu, B.; Grünberger, J.; Anderer, P.; Linzmayer, L. 1996: Effects of the novel neuroprotective agent, riluzole, on human brain function and behavior: II. Double-blind, placebo-controlled EEG mapping and psychometric studies under hypoxia Methods and Findings in Experimental and Clinical Pharmacology 18(1): 67-81
Miyamoto, S. 1972: Evaluation of a new minor tranquilizer, Y-6047, for preanesthetic medication--comparison with a placebo and diazepam by a double blind controlled study Masui. Japanese Journal of Anesthesiology 21(8): 787-795
Shioya, T.; Kagaya, M.; Onodera, A.; Miura, S.; Shindo, T.; Sano, M.; Sasaki, M.; Miura, M. 1996: Effectiveness of the anticholinergic agent oxitropium bromide in elderly patients with bronchial asthma Arzneimittel-Forschung 46(12): 1130-1133
Kalla, N.R.; Gadru, N.; Foo, T.W. 1986: Studies on the male antifertility agent gossypol acetic acid. VII. Effect of motility stimulated factors on the revival of human spermatozoal motility after gossypol treatment in vitro Andrologia 18(4): 393-397
Albot, G.; Veyne-Solodiloff, S. 1971: Combination of a synthetic anticholinergic agent and various enzymes (amylases, lipases, proteases, hemicellulases and cellulases) in the treatment of enteropathies Annales de Gastroenterologie et d'Hepatologie 7(5): 523-528
Murmann, W.; Carminati, G.M.; Cattaneo, R. 1974: Pharmacology of zolimidine (2-(p-methylsulfonylphenyl)-imidazo (1,2-a) pyridine) a new non-anticholinergic gastroprotective agent. I) Protective activity against experimental neurogenic gastric ulcers and other pharmacologic properties Panminerva Medica 16(10): 301-320
Ulmer, W.T.; Dorsch, J.; Iravani, J.; Schüler, K.G.; Stempel, G.; Vastag, E. 1973: Anticholinergic agents as bronchodilator agents. Significance of acetylcholine as a bronchoconstrictor transmitter agent in airway obstruction Arzneimittel-Forschung 23(3): 468-476
Hollán, Z. 1986: Is the HTLV III/LAV virus the causative agent of AIDS or merely an agent of one of the opportunistic infections? Orvosi Hetilap 127(52): 3219-3220
Spencer, J.M.; Accioly, J.; Kitchen, N. 2018: Double Blind, Placebo Controlled Evaluation of a Novel Skin Lightening Agent Journal of Drugs in Dermatology: Jdd 17(1): 113-115
Ziebolz, D.; Hannig, C.; Attin, T. 2008: Influence of a desensitizing agent on efficacy of a paint-on bleaching agent American Journal of Dentistry 21(2): 77-82
Qian, J.-m.; Tang, H. 2013: Status of biological agent therapy in inflammatory bowel disease Zhonghua Wei Chang Wai Ke Za Zhi 16(4): 311-314
Hngo, M. 1990: Effect of acute and long-term administration of a stimulative agent on gastrointestinal motility in the therapy of patients with diabetic gastroparesis Nihon Heikatsukin Gakkai Zasshi 26(2): 70-73
Naess, K. 1973: A beta blocking agent as an antihypertensive agent Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 93(27): 2041